# Ph. 1, Evaluation of Safety, Tolerability, PK, Anti-tumor Activity of STP707 IV in Subjects With Solid Tumors

> **NCT05037149** · PHASE1 · UNKNOWN · sponsor: **Sirnaomics** · enrollment: 50 (actual)

## Conditions studied

- Solid Tumor

## Interventions

- **DRUG:** STP707

## Key facts

- **NCT ID:** NCT05037149
- **Lead sponsor:** Sirnaomics
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-11-01
- **Primary completion:** 2024-03-30
- **Final completion:** 2024-03-30
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2024-03-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05037149

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05037149, "Ph. 1, Evaluation of Safety, Tolerability, PK, Anti-tumor Activity of STP707 IV in Subjects With Solid Tumors". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT05037149. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*